Marshall Wace, LLP Novartis Ag Transaction History

Marshall Wace, LLP

  • $90.8 Billion
  • Q3 2025

A detailed history of Marshall Wace, LLP transactions in Novartis Ag stock. As of the latest transaction made, Marshall Wace, LLP holds 400 shares of NVS stock, worth $52,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 1,431,814 99.97%
Holding current value
$52,620
Previous $173 Million 99.97%
% of portfolio
0.0%
Previous 0.21%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$113.5 - $129.73 $29.9 Million - $34.1 Million
-263,057 Reduced 18.37%
1,168,757 $150 Million
Q2 2025

Aug 13, 2025
SELL
$101.96 - $121.01 $97,983 - $116,290
-961 Reduced 0.07%
1,431,814 $173 Million
Q1 2025

May 15, 2025
BUY
$97.14 - $115.57 $131 Million - $155 Million
1,344,109 Added 1515.92%
1,432,775 $160 Million
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $8.58 Million - $10.4 Million
88,666 New
88,666 $8.63 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $28.7 Million - $32.7 Million
-301,075 Reduced 69.64%
131,247 $12.7 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $57.6 Million - $63.4 Million
-624,720 Reduced 59.1%
432,322 $43.7 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $1.4 Million - $1.55 Million
14,730 Added 1.41%
1,057,042 $108 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $26.3 Million - $29.8 Million
-283,844 Reduced 21.4%
1,042,312 $105 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $41 Million - $47.5 Million
511,869 Added 62.86%
1,326,156 $122 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $4.42 Million - $5.41 Million
-58,454 Reduced 6.7%
814,287 $73.9 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $3.35 Million - $3.92 Million
-44,958 Reduced 4.9%
872,741 $66.3 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $19.2 Million - $22.4 Million
239,038 Added 35.22%
917,699 $77.6 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $41.9 Million - $47.4 Million
522,888 Added 335.67%
678,661 $59.6 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $12.4 Million - $13.7 Million
155,773 New
155,773 $13.6 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $1.5 Million - $1.7 Million
-23,166 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $41,107 - $49,143
-584 Reduced 2.46%
23,166 $1.87 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $722,721 - $775,778
9,992 Added 72.63%
23,750 $1.99 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $1.02 Million - $1.06 Million
13,758
13,758 $1.18 Million

Others Institutions Holding NVS

# of Institutions
1,603
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email